Researchers from several institutions revealed that a novel cancer treatment, consisting of antibody fragments combined with molecularly designed nanoparticles, completely eradicated stomach cancer in treated mice. The “hit and run” medication delivery method resulted from a five-year partnership between Cornell, MSKCC, and biopharmaceutical company AstraZeneca, and their findings were published in the March issue of…

Read More “Nanoparticle therapy is the next step in cancer treatment.” »